Gene Expression Profile and Angiogenic Markers Correlate with Response to Neoadjuvant Bevacizumab Followed by Bevacizumab plus Chemotherapy in Breast Cancer
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.